MedPath
NMPA Approval

Canagliflozin Tablets

国药准字H20243612

April 24, 2024

Drug Information

卡格列净片

片剂

100mg(以卡格列净无水物(C₂₄H₂₅FO₅S)计)

化学药品

April 24, 2024

Company Information

Applicant Company

浙江省义乌市佛堂镇双峰路15号

Manufacturing Company

浙江省义乌市佛堂镇双峰路15号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

卡格列净片 - NMPA 批准文号 | MedPath